Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-26 @ 3:18 AM
Study NCT ID:
NCT04580420
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2020-09-24
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Sponsor:
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2031-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-24
First Submit QC Date:
None
Study First Post Date:
2020-10-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-23
Last Update Post Date:
2025-12-24
Last Update Post Date Type:
ACTUAL